Dr Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE089A01031 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Dr Reddys Labo Dr Reddys Laboratories Ltd. | BSE 1280.00 0.40 (0.03%) | NSE 1278.20 -1.80 (-0.14%) | Trade | Add

BSE Live

Dec 19, 16:01

1280.00 0.40 (0.03%)

Volume

AVERAGE VOLUME

5-Day

75,183

10-Day

100,345

30-Day

70,301

11,355

Prev. Close

1279.60
Open Price

1272.75

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)

NSE Live

Dec 19, 15:55

1278.20 -1.80 (-0.14%)

Volume

AVERAGE VOLUME

5-Day

954,487

10-Day

1,275,013

30-Day

1,663,083

1,209,487

Prev. Close

1280.00
Open Price

1277.00

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
1278.20 (345)

Financials

Print/Copy to Excel : Go

Key Financial Ratios of Dr Reddys Laboratories (in Rs. Cr.)	Mar 10	Mar 09	Mar 08	Mar 07	Mar 06
Per Share Ratios
Basic EPS (Rs.)	20.82	-54.47	26.05	57.52	19.13
Diluted EPS (Rs.)	20.82	-54.47	26.05	57.52	19.13
Cash EPS (Rs.)	46.46	-23.71	51.28	81.16	41.95
Book Value [ExclRevalReserve]/Share (Rs.)	223.74	209.39	267.40	238.06	269.76
Book Value [InclRevalReserve]/Share (Rs.)	223.74	209.39	267.40	238.06	269.76
Revenue from Operations/Share (Rs.)	414.02	408.73	296.30	389.17	308.39
PBDIT/Share (Rs.)	89.97	1.79	62.00	105.51	55.73
PBIT/Share (Rs.)	65.50	-27.77	38.10	82.93	34.65
PBT/Share (Rs.)	63.78	-33.54	32.40	73.84	26.25
Net Profit/Share (Rs.)	20.82	-54.47	26.00	57.50	19.13
NP After MI And SOA / Share (Rs.)	20.82	-54.47	26.05	57.52	19.13
Profitability Ratios
PBDIT Margin (%)	21.73	0.43	20.92	27.11	18.07
PBIT Margin (%)	15.82	-6.79	12.85	21.31	11.23
PBT Margin (%)	15.40	-8.20	10.93	18.97	8.51
Net Profit Margin (%)	5.02	-13.32	8.77	14.77	6.20
NP After MI And SOA Margin (%)	5.02	-13.32	8.79	14.78	6.20
Return on Networth/Equity (%)	9.30	-26.01	9.74	24.16	7.09
Return on Capital Employed (%)	7.36	-18.26	7.19	22.19	6.10
Return on Assets (%)	4.77	-12.52	5.67	12.51	2.31
Total Debt/Equity (X)	0.39	0.57	0.44	0.62	1.51
Asset Turnover Ratio (%)	94.94	93.94	64.58	0.93	0.51
Liquidity Ratios
Current Ratio (X)	1.48	1.68	1.86	2.60	1.34
Quick Ratio (X)	0.96	1.11	1.19	2.08	1.01
Inventory Turnover Ratio (X)	5.22	5.19	4.52	1.66	1.35
Dividend Payout Ratio (NP) (%)	54.06	-11.47	14.39	6.51	26.13
Dividend Payout Ratio (CP) (%)	24.22	-26.37	7.30	4.61	11.91
Earnings Retention Ratio (%)	45.94	111.47	85.61	93.49	73.87
Cash Earnings Retention Ratio (%)	75.78	126.37	92.70	95.39	88.09
Coverage Ratios
Interest Coverage Ratios (%)	38.12	-4.81	6.69	11.61	6.63
Interest Coverage Ratios (Post Tax) (%)	38.12	-4.81	6.69	11.61	6.63
Valuation Ratios
Enterprise Value (Cr.)	22,376.38	9,664.17	11,161.28	12,846.31	13,030.23
EV/Net Operating Revenue (X)	3.20	1.40	2.24	1.97	5.51
EV/EBITDA (X)	14.73	321.07	10.70	7.25	30.48
MarketCap/Net Operating Revenue (X)	3.08	1.20	1.99	1.87	4.61
Retention Ratios (%)	45.93	111.47	85.60	93.48	73.86
Price/BV (X)	5.71	2.33	2.21	3.06	5.27
Price/Net Operating Revenue	3.08	1.20	1.99	1.87	4.61
Earnings Yield	0.02	-0.11	0.04	0.08	0.01